$0.063
0[0.00%]
At close: Apr 24
Aridis Pharmaceuticals
(OTCQB:ARDS)Latest News for Aridis Pharmaceuticals Stock (OTC:ARDS)
Aridis Pharmaceuticals Stock (OTC: ARDS)
Categories: All
Monday, November 06, 2023
Friday, November 03, 2023
Friday, October 20, 2023
Tuesday, July 18, 2023
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga Insights - Jul 18, 2023, 5:32PM
- Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Jul 18, 2023, 1:00PM
- Why Are Aridis Pharmaceuticals Shares Moving Higher Today?Vandana Singh - Jul 18, 2023, 9:09AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Jul 18, 2023, 9:06AM
- Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving PremarketLisa Levin - Jul 18, 2023, 8:12AM
- Aridis Pharmaceuticals shares are trading higher after EMA announced positive feedback on the company's proposed Phase 3 study AR-301 for pneumonia caused by Gram-positive bacteria Staphylococcus aureus in mechanically ventilated hospitalized patients.Benzinga Newsdesk - Jul 18, 2023, 6:12AM
Monday, July 17, 2023
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Jul 17, 2023, 5:32PM
- Aridis Receives Agreement From The European Medicines Agency On The Clinical Study Design And A Single Confirmatory Phase 3 Study Of AR-301Benzinga Newsdesk - Jul 17, 2023, 4:09PM
- Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Jul 17, 2023, 1:14PM
Friday, July 14, 2023
Thursday, July 13, 2023
Wednesday, July 12, 2023
- Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Jul 12, 2023, 12:53PM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Jul 12, 2023, 9:12AM
- Aridis shares are trading higher after the company announced FDA Qualified Infectious Disease Product Designation for AR-301.Benzinga Newsdesk - Jul 12, 2023, 8:17AM
- Aridis Announces FDA Qualified Infectious Disease Product Designation For AR-301Benzinga Newsdesk - Jul 12, 2023, 8:02AM
Thursday, June 08, 2023
Thursday, June 01, 2023
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Jun 1, 2023, 1:31PM
- Why Victoria's Secret Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Jun 1, 2023, 12:58PM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Jun 1, 2023, 9:07AM
- Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving PremarketLisa Levin - Jun 1, 2023, 7:55AM
Wednesday, May 31, 2023
- Why Aridis Pharmaceuticals Shares Are Soaring TodayRyan Gustafson - May 31, 2023, 3:51PM
- Crude Oil Down 2%; Donaldson Shares Drop Following Q3 ResultsLisa Levin - May 31, 2023, 2:39PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - May 31, 2023, 1:31PM
- Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - May 31, 2023, 1:01PM
- Nasdaq Down 100 Points; Advance Auto Parts Earnings Miss ViewsLisa Levin - May 31, 2023, 12:06PM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - May 31, 2023, 9:06AM
- Aridis Pharmaceuticals shares are trading higher after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of AR-301 and the clinical study design.Benzinga Newsdesk - May 31, 2023, 8:15AM
- Aridis Receives Agreement From FDA On A Single Confirmatory Phase 3 Study Of AR-301 And The Clinical Study DesignBenzinga Newsdesk - May 31, 2023, 8:01AM
Thursday, May 25, 2023
Tuesday, May 23, 2023
Wednesday, April 26, 2023
Monday, April 10, 2023
Thursday, April 06, 2023
Monday, April 03, 2023
Friday, March 31, 2023
Wednesday, March 29, 2023
- AstraZeneca Axes Pneumonia Drug Pact With AridisVandana Singh - Mar 29, 2023, 1:17PM
- Aridis Pharmaceuticals Said On March 20, Got Written Notice From Medimmune That It Has Terminated License Agreement Dated As Of July 12, 2021 Effective March 30; As Result Of Termination Notice, On-going Ar-320-003 Phase 3 Clinical Study Must Be Put On HoldCharles Gross - Mar 29, 2023, 6:05AM
Tuesday, March 14, 2023
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Mar 14, 2023, 1:31PM
- Stocks That Hit 52-Week Lows On TuesdayBenzinga Insights - Mar 14, 2023, 1:24PM
- Why RAPT Therapeutics Shares Are Trading Lower By Over 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Mar 14, 2023, 1:07PM
- Why Aridis Pharmaceuticals Shares Are DivingHenry Khederian - Mar 14, 2023, 11:24AM
- Aridis Pharmaceuticals shares are trading lower after the company announced a $2.28 million registered direct offering.Michael Horton - Mar 14, 2023, 10:37AM
- Aridis Pharmaceuticals Announces $2.28M OfferingBenzinga Newsdesk - Mar 14, 2023, 9:45AM
Monday, March 13, 2023
- Aridis Pharmaceuticals Says On March 10 Co. Received Notice From Nasdaq Indicating Bid Price For Co.'s Common Stock For Last 30 Consecutive Business Days Had Closed Below Minimum $1.00/ShareMichael Horton - Mar 13, 2023, 4:09PM
- Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Mar 13, 2023, 1:22PM